| |
| |
| Exchange: |
|
| Security
Type: |
|
| Shares
Out: |
10,661,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
|
| Level
II Sector: |
|
| Level
III Sector: |
|
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Journey Medical is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Co.'s portfolio includes five branded and three authorized generic prescription drugs. Co.'s marketed products include: Qbrexza®, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane®, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Targadox®, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino®, an oral minocycline drug for the treatment of acne; and Exelderm® Cream and Solution, an antifungal intended for topical use.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
70,000 |
70,000 |
274,044 |
274,044 |
| Total Buy Value |
$237,290 |
$237,290 |
$758,061 |
$758,061 |
| Total People Bought |
3 |
3 |
4 |
4 |
| Total Buy Transactions |
4 |
4 |
9 |
9 |
| Total Shares Sold |
2,450 |
6,695 |
75,911 |
88,772 |
| Total Sell Value |
$9,188 |
$27,069 |
$128,451 |
$158,228 |
| Total People Sold |
1 |
2 |
3 |
4 |
| Total Sell Transactions |
1 |
4 |
8 |
10 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rosenwald Lindsay A Md |
Director |
– • – |
2024-03-25 |
4 |
B |
$3.04 |
$30,400 |
D/D |
10,000 |
144,245 |
2.39 |
- |
|
| Smith Justin Adam |
Director |
– • – |
2024-03-22 |
4 |
B |
$3.47 |
$104,100 |
D/D |
30,000 |
134,717 |
2.39 |
- |
|
| Rosenwald Lindsay A Md |
Director |
– • – |
2024-03-22 |
4 |
B |
$3.40 |
$68,000 |
D/D |
20,000 |
134,245 |
2.39 |
- |
|
| Maraoui Claude |
President & CEO |
• • – |
2024-03-22 |
4 |
B |
$3.48 |
$34,790 |
D/D |
10,000 |
2,163,430 |
2.81 |
- |
|
| Benesch Joseph |
Interim CFO |
• – – |
2024-02-22 |
4 |
S |
$3.75 |
$9,188 |
D/D |
(2,450) |
60,710 |
|
- |
|
| Paley Jeffrey |
Director |
– • – |
2023-11-28 |
4 |
S |
$5.22 |
$9,109 |
D/D |
(1,745) |
70,727 |
|
- |
|
| Paley Jeffrey |
Director |
– • – |
2023-11-08 |
4 |
S |
$3.76 |
$959 |
D/D |
(255) |
114,217 |
|
- |
|
| Paley Jeffrey |
Director |
– • – |
2023-11-07 |
4 |
S |
$3.48 |
$7,813 |
D/D |
(2,245) |
114,472 |
|
- |
|
| Smith Justin Adam |
Director |
– • – |
2023-10-13 |
4 |
B |
$2.98 |
$98,340 |
D/D |
33,000 |
104,717 |
2.39 |
- |
|
| Paley Jeffrey |
Director |
– • – |
2023-10-06 |
4 |
B |
$2.98 |
$44,700 |
D/D |
15,000 |
72,472 |
2.39 |
- |
|
| Paley Jeffrey |
Director |
– • – |
2023-09-21 |
4 |
B |
$2.97 |
$89,100 |
D/D |
30,000 |
57,472 |
2.39 |
- |
|
| Maraoui Claude |
President & CEO |
• • – |
2023-09-06 |
4 |
B |
$2.52 |
$65,631 |
D/D |
26,044 |
2,153,430 |
2.81 |
- |
|
| Rosenwald Lindsay A Md |
Director |
– • – |
2023-09-06 |
4 |
B |
$2.23 |
$223,000 |
D/D |
100,000 |
114,245 |
2.39 |
- |
|
| Maraoui Claude |
President & CEO |
• • – |
2023-07-24 |
4 |
S |
$1.76 |
$36,550 |
D/D |
(20,767) |
2,127,386 |
|
- |
|
| Benesch Joseph |
See Remarks |
• – – |
2023-07-24 |
4 |
S |
$1.76 |
$7,167 |
D/D |
(4,072) |
63,160 |
|
- |
|
| Smith Justin Adam |
Director |
– • – |
2023-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
27,472 |
71,717 |
|
- |
|
| Herskowitz Neil |
Director |
– • – |
2023-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
27,472 |
71,717 |
|
- |
|
| Toledano Miranda Jayne |
Director |
– • – |
2023-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
27,472 |
71,717 |
|
- |
|
| Paley Jeffrey |
Director |
– • – |
2023-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
27,472 |
71,717 |
|
- |
|
| Maraoui Claude |
President & CEO |
• • – |
2023-05-17 |
4 |
S |
$1.34 |
$32,665 |
D/D |
(24,377) |
2,148,153 |
|
- |
|
| Maraoui Claude |
President & CEO |
• • – |
2023-05-16 |
4 |
S |
$1.25 |
$25,000 |
D/D |
(20,000) |
2,172,530 |
|
- |
|
| Benesch Joseph |
Interim CFO |
• – – |
2023-02-22 |
4 |
S |
$1.97 |
$5,453 |
D/D |
(2,768) |
67,232 |
|
- |
|
| Benesch Joseph |
Interim CFOOfficer |
• – – |
2023-01-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,000 |
|
- |
|
| De Paolantonio Ernest Robert |
Chief Financial Officer |
• – – |
2022-10-04 |
4 |
S |
$2.41 |
$24,324 |
D/D |
(10,093) |
259,907 |
|
- |
|
| Paley Jeffrey |
Director |
– • – |
2022-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
14,245 |
44,245 |
|
- |
|
38 Records found
|
|
Page 1 of 2 |
|
|
